The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
Open accessAbstract
Serum paraoxonase (PON1), present on high density lipoprotein, may inhibit low density lipoprotein (LDL) oxidation and protect against atherosclerosis. We generated combined PON1 knockout (KO)/apolipoprotein E (apoE) KO and apoE KO control mice to compare atherogenesis and lipoprotein oxidation. Early lesions were examined in 3-month-old mice fed a chow diet, and advanced lesions were examined in 6-month-old mice fed a high fat diet. In both cases, the PON1 KO/apoE KO mice exhibited significantly more atherosclerosis (50-71% increase) than controls. We examined LDL oxidation and clearance in vivo by injecting human LDL into the mice and following its turnover. LDL clearance was faster in the double KO mice as compared with controls. There was a greater rate of accumulation of oxidized phospholipid epitopes and a greater accumulation of LDL-immunoglobulin complexes in the double KO mice than in controls. Furthermore, the amounts of three bioactive oxidized phospholipids were elevated in the endogenous intermediate density lipoprotein/LDL of double KO mice as compared with the controls. Finally, the expression of heme oxygenase-1, peroxisome proliferator-activated receptor gamma, and oxidized LDL receptors were elevated in the livers of double KO mice as compared with the controls. These data demonstrate that PON1 deficiency promotes LDL oxidation and atherogenesis in apoE KO mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Self-citationStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Book ReviewAmbulatory Pediatric Care
Steinberg, J. B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901053200122 · Cited by 2,108
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
Self-citationLow Density Lipoprotein Oxidation and Its Pathobiological Significance
Steinberg, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20963 · Cited by 1,642
Low density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,519
Self-citationAutoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssonen, K., Yla-Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,316
Self-citationCD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,281
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,224
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Self-citationCushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5134 · Cited by 1,146
Self-citationMice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Self-citationParaoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
Berliner, J. A., Territo, M. C., Sevanian, A., Ramin, S., Kim, J. A., Bamshad, B., Esterson, M., & Fogelman, A. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114562 · Cited by 925
Self-citationChawla, A., Schwarz, E. J., Dimaculangan, D. D., & Lazar, M. A. (1994) · Endocrinology · doi:10.1210/en.135.2.798 · Cited by 873
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 855
Self-citationHigh-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
Parthasarathy, S., Barnett, J., & Fong, L. G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90314-n · Cited by 827
Kume, N., Cybulsky, M. I., & Gimbrone, M. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115932 · Cited by 824
Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., & Lusis, A. J. (1990) · Nature · doi:10.1038/344254a0 · Cited by 776
Self-citationWatson, A. D., Leitinger, N., Navab, M., Faull, K. F., Hörkkö, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13597 · Cited by 753
Self-citationNavab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Self-citationSmith, J. D., Trogan, E., Ginsberg, M., Grigaux, C., Tian, J., & Miyata, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8264 · Cited by 724
Ricote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witztum, J. L., Auwerx, J., Palinski, W., & Glass, C. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7614 · Cited by 721
Self-citationNavab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., et al. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.7.831 · Cited by 692
Self-citationGosling, J., Slaymaker, S., Gu, L., Tseng, S., Zlot, C. H., Young, S. G., Rollins, B. J., & Charo, I. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5624 · Cited by 660
Hörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Self-citationPalinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., & Witztum, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118853 · Cited by 559
Self-citationRabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
Ylä-Herttuala, S., Palinski, W., Butler, S. W., Picard, S., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.32 · Cited by 548
Self-citationDisruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
Self-citationTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Praticò, D., Tangirala, R. K., Rader, D. J., Rokach, J., & FitzGerald, G. A. (1998) · Nature Medicine · doi:10.1038/2685 · Cited by 501
Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.605 · Cited by 488
Self-citationGarin, M. C., James, R. W., Dussoix, P., Blanché, H., Passa, P., Froguel, P., & Ruiz, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119134 · Cited by 476
Steinbrecher, U. P., Witztum, J. L., Parthasarathy, S., & Steinberg, D. (1987) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.7.2.135 · Cited by 468
Self-citationA role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
Parthasarathy, S., Wieland, E., & Steinberg, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.1046 · Cited by 415
Watson, A. D., Navab, M., Hama, S. Y., Sevanian, A., Prescott, S. M., Stafforini, D. M., McIntyre, T. M., Du, B. N., Fogelman, A. M., & Berliner, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117726 · Cited by 403
Self-citationLeeuwenburgh, C., Rasmussen, J. E., Hsu, F. F., Mueller, D. M., Pennathur, S., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3520 · Cited by 361
BLATTER, M., JAMES, R. W., MESSMER, S., BARJA, F., & POMETTA, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes
Ruiz, J., Morabia, A., Blanche, H., James, R. W., Garin, M.-C. B., Charpentier, G., Passa, P., Vaisse, C., Ruiz, J., & Froguel, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92709-3 · Cited by 344
Serrato, M., & Marian, A. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118373 · Cited by 339
Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.
Qiao, J. H., Tripathi, J., Mishra, N. K., Cai, Y., Tripathi, S., Wang, X. P., Imes, S., Fishbein, M. C., Clinton, S. K., Libby, P., et al. (1997) · Europe PMC (PubMed Central) · Cited by 329
Self-citationRamprasad, M. P., Fischer, W., Witztum, J. L., Sambrano, G. R., Quehenberger, O., & Steinberg, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9580 · Cited by 315
Self-citationStremler, K. E., Stafforini, D. M., Prescott, S. M., & McIntyre, T. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99132-5 · Cited by 310
Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.
Ishikawa, K., Navab, M., Leitinger, N., Fogelman, A. M., & Lusis, A. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119634 · Cited by 289
Self-citationVan Berkel, T. J., De Rijke, Y. B., & Kruijt, J. K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52241-9 · Cited by 278
Shih, D. M., Gu, L., Hama, S., Xia, Y. R., Navab, M., Fogelman, A. M., & Lusis, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118589 · Cited by 247
Self-citationHeterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice.
Rajavashisth, T., Qiao, J. H., Tripathi, S., Tripathi, J., Mishra, N., Hua, M., Wang, X. P., Loussararian, A., Clinton, S., Libby, P., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119891 · Cited by 247
Self-citationStremler, K. E., Stafforini, D. M., Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83548-7 · Cited by 227
Freeman, M., Ekkel, Y., Rohrer, L., Penman, M., Freedman, N. J., Chisolm, G. M., & Krieger, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4931 · Cited by 210
Watson, A. D., Subbanagounder, G., Welsbie, D. S., Faull, K. F., Navab, M., Jung, M. E., Fogelman, A. M., & Berliner, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24787 · Cited by 206
Self-citationParaoxonase and coronary heart disease
Mackness, M. I., Mackness, B., Durrington, P. N., Fogelman, A. M., Berliner, J., Lusis, A. J., Navab, M., Shih, D., & Fonarow, G. C. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199808000-00006 · Cited by 204
Self-citationYoshida, H., Quehenberger, O., Kondratenko, N., Green, S., & Steinberg, D. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.5.794 · Cited by 194
Involvement of 15-lipoxygenase in early stages of atherogenesis.
Kühn, H., Belkner, J., Zaiss, S., Fährenklemper, T., & Wohlfeil, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.6.1903 · Cited by 193
Apolipoprotein J Is Associated with Paraoxonase in Human Plasma
Kelso, G. J., Stuart, W. D., Richter, R. J., Furlong, C. E., Jordan-Starck, T. C., & Harmony, J. A. K. (1994) · Biochemistry · doi:10.1021/bi00169a026 · Cited by 179
Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
Hedrick, C. C., Castellani, L. W., Warden, C. H., Puppione, D. L., & Lusis, A. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80777-7 · Cited by 175
Self-citationIncreased Plasma and Lipoprotein Lipid Peroxidation in apo E-Deficient Mice
Hayek, T., Oiknine, J., Brook, J. G., & Aviram, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1883 · Cited by 171
Serum paraoxonase status: A major factor in determining resistance to organophosphates
Li, W., Costa, L. G., & Furlong, C. E. (1993) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399309531798 · Cited by 167
Lopes-Virella, M. F., Virella, G., Orchard, T. J., Koskinen, S., Evans, R. G., BECKER, D. J., & Forrest, K. Y. Z. (1999) · Clinical Immunology · doi:10.1006/clim.1998.4631 · Cited by 154
Leitinger, N., Watson, A. D., Hama, S. Y., Ivandic, B., Qiao, J.-H., Huber, J., Faull, K. F., Grass, D., Navab, M., Fogelman, A. M., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1291 · Cited by 154
Self-citationOttnad, E., Parthasarathy, S., Sambrano, G. R., Ramprasad, M. P., Quehenberger, O., Kondratenko, N., Green, S., & Steinberg, D. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1391 · Cited by 144
Hörkkö, S., Miller, E. R., Branch, D. W., Palinski, W., & Witztum, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10356 · Cited by 138
Self-citationYoung, S. G., Witztum, J. L., Casal, D., Curtiss, L. K., & Bernstein, S. (1986) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.6.2.178 · Cited by 135
Self-citationLysophosphatidylcholine induces the production of IL-1β by human monocytes
Liu‐Wu, Y., Hurt‐Camejo, E., & Wiklund, O. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00295-5 · Cited by 133
Murohara, T., Scalia, R. G., & Lefer, A. M. (1996) · Circulation Research · doi:10.1161/01.res.78.5.780 · Cited by 131
Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice.
Mehrabian, M., Qiao, J. H., Hyman, R., Ruddle, D. L., Laughton, C. W., & Lusis, A. J. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.1.1 · Cited by 130
Self-citationLipoprotein-antibody immune complexes their catabolism and role in foam cell formation
Klimov, A. N., Denisenko, A. D., Popov, A. V., Nagornev, V. A., Pleskov, V. M., Vinogradov, A. G., Denisenko, T. V., Magracheva, E., Kheifes, G. M., & Kuznetzov, A. S. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90051-6 · Cited by 96
Takahara, N., Kashiwagi, A., Maegawa, H., & Shigeta, Y. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90024-4 · Cited by 88
Sugiyama, S., Kugiyama, K., Ogata, N., Doi, H., Ota, Y., Ohgushi, M., Matsumura, T., Oka, H., & Yasue, H. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.4.568 · Cited by 85
Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B.
Young, S. G., Smith, R. S., Hogle, D. M., Curtiss, L. K., & Witztum, J. L. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.8.1484 · Cited by 75
Self-citationScavenger Receptor BI Mediates the Selective Uptake of Oxidized Cholesterol Esters by Rat Liver
Fluiter, K., Sattler, W., de Beer, M. C., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8893 · Cited by 73
Woollett, L. A., Osono, Y., Herz, J., & Dietschy, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12500 · Cited by 55
Wiklund, O., Witztum, J. L., Carew, T. E., Pittman, R. C., Elam, R. L., & Steinberg, D. H. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38623-5 · Cited by 52
Self-citationAre Immunological Mechanisms Relevant for the Development of Atherosclerosis?
Witztum, J. L., & Palinski, W. (1999) · Clinical Immunology · doi:10.1006/clim.1998.4682 · Cited by 30
Self-citation
Cited by
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Self-citationGlass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Self-citationOxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Metadata
- Authors
- Shih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., & Lusis, A. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 275
- Issue
- 23
- Pages
- 17527-17535
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2168115093
- Cited by
- 425
- References
- 80
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.